Cancer Research Landon Prizes for Basic and Translational Cancer Research Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andela, V. B.
Right arrow Articles by Rosier, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andela, V. B.
Right arrow Articles by Rosier, R. N.
[Cancer Research 60, 6557-6562, December 1, 2000]
© 2000 American Association for Cancer Research

Advances in Brief

Tumor Metastasis and the Reciprocal Regulation of Prometastatic and Antimetastatic Factors by Nuclear Factor {kappa}B

Valentine B. Andela, Edward M. Schwarz, J. Edward Puzas, Regis J. O’Keefe and Randy N. Rosier1

Department of Orthopaedics [V. B. A., J. E. P., R. J. O., R. N. R.] and Immunology/Rheumatology Unit, Department of Medicine [E. M. S.], University of Rochester, Rochester, New York 14642

To investigate the role of the transcription factor nuclear factor {kappa}B (NF{kappa}B) in tumor metastasis, we generated a murine lung alveolar carcinoma cell line (Line 1) defective in NF{kappa}B-signaling by retroviral delivery of a dominant negative inhibitor of NF{kappa}B. The NF{kappa}B signal blockade resulted in the down-regulation of prometastatic matrix metalloproteinase 9, a urokinase-like plasminogen activator, and heparanase and reciprocal up-regulation of antimetastatic tissue inhibitors of matrix metalloproteinases 1 and 2 and plasminogen activator inhibitor 2. NF{kappa}B signal blockade did not affect tumor cell proliferation in vitro or in vivo but prevented intravasation of tumor cells in an in vivo chick chorioallantoic membrane model of metastasis as well as spontaneous metastasis in a murine model. These findings suggest that NF{kappa}B plays a central and specific role in the regulation of tumor metastasis and may be an important therapeutic target for development of antimetastatic cancer treatments.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. O. Rehman and C.-Y. Wang
SDF-1{alpha} Promotes Invasion of Head and Neck Squamous Cell Carcinoma by Activating NF-{kappa}B
J. Biol. Chem., July 18, 2008; 283(29): 19888 - 19894.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
G. T. Stathopoulos, T. P. Sherrill, W. Han, R. T. Sadikot, F. E. Yull, T. S. Blackwell, and B. Fingleton
Host Nuclear Factor-{kappa}B Activation Potentiates Lung Cancer Metastasis
Mol. Cancer Res., March 1, 2008; 6(3): 364 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
C. Guruvayoorappan and G. Kuttan
Effect of Amentoflavone on the Inhibition of Pulmonary Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice
Integr Cancer Ther, June 1, 2007; 6(2): 185 - 197.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
J. E. Harris, R. K. Nuttall, P. T. Elkington, J. A. Green, D. E. Horncastle, M. B. Graeber, D. R. Edwards, and J. S. Friedland
Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo
J. Immunol., January 15, 2007; 178(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Kishida, H. Yoshikawa, and A. Myoui
Parthenolide, a Natural Inhibitor of Nuclear Factor-{kappa}B, Inhibits Lung Colonization of Murine Osteosarcoma Cells
Clin. Cancer Res., January 1, 2007; 13(1): 59 - 67.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. G. Uzzo, P. L. Crispen, K. Golovine, P. Makhov, E. M. Horwitz, and V. M. Kolenko
Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression
Carcinogenesis, October 1, 2006; 27(10): 1980 - 1990.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Kukreja, A. B. Abdel-Mageed, D. Mondal, K. Liu, and K. C. Agrawal
Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1{alpha} (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway-Dependent NF-{kappa}B Activation
Cancer Res., November 1, 2005; 65(21): 9891 - 9898.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Jorda, D. Olmeda, A. Vinyals, E. Valero, E. Cubillo, A. Llorens, A. Cano, and A. Fabra
Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor
J. Cell Sci., August 1, 2005; 118(15): 3371 - 3385.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. H. Gordon, R. J. O'Keefe, E. M. Schwarz, R. N. Rosier, and J. E. Puzas
Nuclear Factor-{kappa}B-Dependent Mechanisms in Breast Cancer Cells Regulate Tumor Burden and Osteolysis in Bone
Cancer Res., April 15, 2005; 65(8): 3209 - 3217.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
V B Andela, F Siddiqui, A Groman, and R N Rosier
An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF{kappa}B in human osteosarcoma
J. Clin. Pathol., March 1, 2005; 58(3): 328 - 330.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, H. Seino-Noda, et al.
Inhibition of Inhibitor of Nuclear Factor-{kappa}B Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models
Clin. Cancer Res., November 15, 2004; 10(22): 7645 - 7654.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Yamamoto, Y. Tomita, Y. Hoshida, S. Toyosawa, H. Inohara, M. Kishino, M. Kogo, M. Nakazawa, S. Murakami, N. Iizuka, et al.
Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
Ann. Onc., September 1, 2004; 15(9): 1432 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. N. Papandreou and C. J. Logothetis
Bortezomib as a Potential Treatment for Prostate Cancer
Cancer Res., August 1, 2004; 64(15): 5036 - 5043.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Yamamoto, Y. Tomita, Y. Hoshida, N. Iizuka, M. Monden, S. Yamamoto, K. Iuchi, and K. Aozasa
Expression Level of Valosin-Containing Protein (p97) Is Correlated With Progression and Prognosis of Non-Small-Cell Lung Carcinoma
Ann. Surg. Oncol., July 1, 2004; 11(7): 697 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, M. Saito, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, et al.
Inhibition of NF{kappa}B Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
J. Biol. Chem., May 28, 2004; 279(22): 23477 - 23485.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Bien, C. A. Ritter, M. Gratz, B. Sperker, J. Sonnemann, J. F. Beck, and H. K. Kroemer
Nuclear Factor-{kappa}B Mediates Up-Regulation of Cathepsin B by Doxorubicin in Tumor Cells
Mol. Pharmacol., May 1, 2004; 65(5): 1092 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Yamamoto, Y. Tomita, Y. Hoshida, S. Takiguchi, Y. Fujiwara, T. Yasuda, M. Yano, S. Nakamori, M. Sakon, M. Monden, et al.
Expression Level of Valosin-Containing Protein Is Strongly Associated With Progression and Prognosis of Gastric Carcinoma
J. Clin. Oncol., July 1, 2003; 21(13): 2537 - 2544.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Karashima, P. Sweeney, A. Kamat, S. Huang, S. J. Kim, M. Bar-Eli, D. J. McConkey, and C. P. N. Dinney
Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8
Clin. Cancer Res., July 1, 2003; 9(7): 2786 - 2797.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Helbig, K. W. Christopherson II, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer, and H. Nakshatri
NF-{kappa} B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
J. Biol. Chem., June 6, 2003; 278(24): 21631 - 21638.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Belluco, F. Olivieri, M. Bonafe, S. Giovagnetti, E. Mammano, R. Scalerta, A. Ambrosi, C. Franceschi, D. Nitti, and M. Lise
-174G>C Polymorphism of Interleukin 6 Gene Promoter Affects Interleukin 6 Serum Level in Patients with Colorectal Cancer
Clin. Cancer Res., June 1, 2003; 9(6): 2173 - 2176.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. C. Hodge, J. Bub, S. Kaul, A. Kajdacsy-Balla, and P. F. Lindholm
Requirement of RhoA Activity for Increased Nuclear Factor {kappa}B Activity and PC-3 Human Prostate Cancer Cell Invasion
Cancer Res., March 15, 2003; 63(6): 1359 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. H. Ma, H. H. Yang, K. Parker, S. Manyak, J. M. Friedman, C. Altamirano, Z.-q. Wu, M. J. Borad, M. Frantzen, E. Roussos, et al.
The Proteasome Inhibitor PS-341 Markedly Enhances Sensitivity of Multiple Myeloma Tumor Cells to Chemotherapeutic Agents
Clin. Cancer Res., March 1, 2003; 9(3): 1136 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Wang, B. J. Manning, Q. D. Wu, S. Blankson, D. Bouchier-Hayes, and H. P. Redmond
Endotoxin/Lipopolysaccharide Activates NF-{kappa}B and Enhances Tumor Cell Adhesion and Invasion Through a {beta}1 Integrin-Dependent Mechanism
J. Immunol., January 15, 2003; 170(2): 795 - 804.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.